Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.325 USD | -2.09% | -6.33% | -28.98% |
May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.98% | 5.5M | |
+32.74% | 50.85B | |
+0.18% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.69% | 26.11B | |
-22.20% | 19.13B | |
+8.47% | 13.05B | |
+27.25% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Transcript : Seneca Biopharma, Inc. - Shareholder/Analyst Call